Cargando…

The emerging roles of N6-methyladenosine RNA modifications in thyroid cancer

Thyroid cancer (TC) is the most predominant malignancy of the endocrine system, with steadily growing occurrence and morbidity worldwide. Although diagnostic and therapeutic methods have been rapidly developed in recent years, the underlying molecular mechanisms in the pathogenesis of TC remain enig...

Descripción completa

Detalles Bibliográficos
Autores principales:	Xu, Xiaoxin, Zhao, Jiayao, Yang, Mingyue, Han, Lutuo, Yuan, Xingxing, Chi, Wencheng, Jiang, Jiakang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2023
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10621220/ https://www.ncbi.nlm.nih.gov/pubmed/37915103 http://dx.doi.org/10.1186/s40001-023-01382-2

Ejemplares similares

Modification of N(6)-methyladenosine RNA methylation on heat shock protein expression
por: Yu, Jiayao, et al.
Publicado: (2018)

Emerging role of RNA modification N6-methyladenosine in immune evasion
por: Lou, Xin, et al.
Publicado: (2021)

The Emerging Role of RNA N6-Methyladenosine Modification in Pancreatic Cancer
por: Hu, Xiaoge, et al.
Publicado: (2022)

Mechanism of RNA modification N6-methyladenosine in human cancer
por: Zhou, Zijian, et al.
Publicado: (2020)

Function and evolution of RNA N6-methyladenosine modification
por: Zhu, Zhi-Man, et al.
Publicado: (2020)

RNA N(6)-Methyladenosine Modifications and the Immune Response
por: Wang, Ya-Nan, et al.
Publicado: (2020)

Emerging Roles of N6-Methyladenosine Modification in Neurodevelopment and Neurodegeneration
por: Shu, Liqi, et al.
Publicado: (2021)

N(6)-methyladenosine (m(6)A) RNA modification in tumor immunity
por: Zheng, Siyi, et al.
Publicado: (2022)

Emerging roles of the RNA modifications N6-methyladenosine and adenosine-to-inosine in cardiovascular diseases
por: Sikorski, Vilbert, et al.
Publicado: (2022)

N6-methyladenosine RNA modification: an emerging molecule in type 2 diabetes metabolism
por: Zhang, Haocheng, et al.
Publicado: (2023)

Role of N(6)-Methyladenosine RNA Modification in Cardiovascular Disease
por: Song, Dandan, et al.
Publicado: (2021)

Role of N6-methyladenosine RNA modification in gastric cancer
por: Ding, Si-Qi, et al.
Publicado: (2023)

N6-Methyladenosine RNA Modification Landscape in the Occurrence and Recurrence of Nasopharyngeal Carcinoma
por: Wang, Yu Min, et al.
Publicado: (2022)

Emerging Perspectives of RNA N(6)-methyladenosine (m(6)A) Modification on Immunity and Autoimmune Diseases
por: Tang, Lipeng, et al.
Publicado: (2021)

The functions of N6-methyladenosine modification in lncRNAs
por: He, Rong-Zhang, et al.
Publicado: (2020)

N(6)-Methyladenosine RNA Modification: An Emerging Immunotherapeutic Approach to Turning Up Cold Tumors
por: Zhan, Lei, et al.
Publicado: (2021)

Regulation of RNA N(6)-methyladenosine modification and its emerging roles in skeletal muscle development
por: Li, Jiju, et al.
Publicado: (2021)

Function of N6-Methyladenosine Modification in Tumors
por: Zhang, Nan, et al.
Publicado: (2021)

N(6)‐methyladenosine (m(6)A) RNA modification in human cancer
por: Huo, Fu‐Chun, et al.
Publicado: (2020)

The Role of N(6)-Methyladenosine Modification in Microvascular Dysfunction
por: Zhang, Ye-Ran, et al.
Publicado: (2022)

N6-Methyladenosine RNA modification in cerebrospinal fluid as a novel potential diagnostic biomarker for progressive multiple sclerosis
por: Ye, Fei, et al.
Publicado: (2021)

RNA N(6)-methyladenosine modification in cancers: current status and perspectives
por: Deng, Xiaolan, et al.
Publicado: (2018)

The RNA Modification N(6)-methyladenosine and Its Implications in Human Disease
por: Batista, Pedro J.
Publicado: (2017)

Epigenetic N6-methyladenosine modification of RNA and DNA regulates cancer
por: Liang, Zhixian, et al.
Publicado: (2020)

N6-Methyladenosine RNA Modification in Inflammation: Roles, Mechanisms, and Applications
por: Luo, Jiahui, et al.
Publicado: (2021)

RNA N6-Methyladenosine Modifications and Its Roles in Alzheimer’s Disease
por: Zhang, Runjiao, et al.
Publicado: (2022)

Importance of N(6)-methyladenosine RNA modification in lung cancer (Review)
por: Wang, Yueyang, et al.
Publicado: (2021)

Functions of RNA N(6)-methyladenosine modification in acute myeloid leukemia
por: Zheng, Xue, et al.
Publicado: (2021)

The Roles of N6-Methyladenosine Modification in Plant–RNA Virus Interactions
por: He, Min, et al.
Publicado: (2023)

Detection, regulation, and functions of RNA N(6)-methyladenosine modification in plants
por: Tang, Jun, et al.
Publicado: (2023)

RNA N(6)-methyladenosine modification in female reproductive biology and pathophysiology
por: Huang, Erqing, et al.
Publicado: (2023)

Emerging roles of N6-methyladenosine (m(6)A) modification in breast cancer
por: Wang, Yanyan, et al.
Publicado: (2020)

Insights into N6-methyladenosine (m6A) modification of noncoding RNA in tumor microenvironment
por: Zhang, YanJun, et al.
Publicado: (2023)

Connecting N6‐methyladenosine modification to ferroptosis resistance in hepatoblastoma
por: Peng, Wan‐Xin, et al.
Publicado: (2022)

N6-Methyladenosine Modification Opens a New Chapter in Circular RNA Biology
por: Wu, Jun, et al.
Publicado: (2021)

The emerging role of RNA N6-methyladenosine methylation in breast cancer
por: Zheng, Fangchao, et al.
Publicado: (2021)

Roles of N(6)‐methyladenosine (m(6)A) RNA modifications in urological cancers
por: Wang, Xiao, et al.
Publicado: (2020)

Role of main RNA modifications in cancer: N(6)-methyladenosine, 5-methylcytosine, and pseudouridine
por: Xue, Chen, et al.
Publicado: (2022)

Detection of N(6)-methyladenosine modification residues (Review)
por: Zhu, Wei, et al.
Publicado: (2019)

Evolution of transcript modification by N(6)-methyladenosine in primates
por: Ma, Lijia, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_5d8aphplvlslie367f3c3c0amb